Pharma BD Deal Intelligence
Pfizer Inc. / Pharmacia Corporation
2002 · Acquisition/Merger · $60.0B · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
67
Largely worked — most objectives met.
Pfizer acquired Pharmacia Corporation for approximately $60 billion in an all-stock transaction, gaining blockbuster drugs Celebrex and Bextra along with a strong oncology pipeline including Camptosar, creating the world's largest pharmaceutical company at the time.
Key facts
Announced Jul 15, 2002 Closed Apr 16, 2003 Deal value $60.0B Deal type Acquisition/Merger Therapeutic area Immunology, Neurology, Oncology, Ophthalmology Indications Arthritis, Pain, Colorectal cancer, Glaucoma, Overactive bladder, Growth disorders Key assets Celebrex (celecoxib), Bextra (valdecoxib), Camptosar (irinotecan), Xalatan (latanoprost), Detrol (tolterodine), Genotropin (somatropin), Depo-Provera (medroxyprogesterone), Monsanto agricultural chemicals business (spun off prior) Mechanism COX-2 selective inhibitor, Topoisomerase I inhibitor, Prostaglandin F2-alpha analog, Muscarinic receptor antagonist
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
The Pharma Closeout — Deal Intelligence Database.
Announcement Sentiment and Outcome Score from sourced facts.Home ·
Deals ·
Methodology ·
About